2021 American Transplant Congress Archives - Page 19 of 139

ATC 2021 Virtual Connect is an all-new, completely enhanced virtual meeting experience. The ATC program is built in Eastern Time Zone.

Lacripep^TM-like Peptide N-104 Increases Insulin Secretion and Promotes Islet Transplantation Outcomes

M. Ma, P. Chhabra, K. Dias Teixeira, G. Laurie, K. Brayman
Lacripep^TM-like Peptide N-104 Promotes Beta Cell Proliferation in Murine Pancreatic Islets

M. Ma, P. Chhabra, K. Fread, K. Dias Teixeira, G. Laurie, K. Brayman
Laminin Alpha 4 and Alpha5 Differentially Regulate Lymph Node Tolerogenic Structure

L. Li¹, M. Shirkey¹, W. Piao¹, Y. Xiong¹, V. Saxena¹, T. Zhang¹, J. Iyyathurai², R. Lakhan¹, R. Abdi³, J. Bromberg¹
Laminins Differentially Regulate Adaptive Alloimmune Responses

L. Li¹, M. Shirkey¹, W. Piao¹, Y. Xiong¹, V. Saxena¹, T. Zhang¹, J. Iyyathurai², R. Lakhan¹, R. Abdi³, J. Bromberg¹
Laminins Differentially Regulate Tolerogenic T Cell Migration and Homing to Lymph Nodes

L. Li¹, M. Shirkey¹, W. Piao¹, Y. Xiong¹, V. Saxena², T. Zhang¹, J. Iyyathurai², R. Lakhan¹, R. Abdi³, J. Bromberg¹
Late Subclinical Rejection and Borderline Rejection in Kidney Transplant Patients is Associated with Increased Incidence of Subsequent Clinical Rejections

V. Viswanathan¹, I. Melgarejo², C. Puttarajappa², P. Sood², M. Molinari², S. Hariharan², C. Wu², A. Sharma², N. Shah², R. Mehta²
Launching a National Living Donor Registry

J. E. Milton¹, M. Cooper², B. Hippen³
Leflunomide Therapy for Treatment of Bk Viremia in Pediatric Kidney Transplant Recipients

A. Aldieri¹, M. Chandran², D. Matossian³, B. Magella⁴, D. Lazear⁴, M. Bock², E. Blanchette²
Letermovir Prophylaxis in Solid Organ Transplant – CMV Breakthrough and Tacrolimus Drug Interaction

R. Winstead¹, D. Kumar¹, A. Brown¹, I. Yakubu¹, C. Song¹, L. Thacker², G. Gupta¹
Leukopenia in the Renal Transplant Population

A. Johnson¹, G. Karadkhele², C. Larsen¹
Life-supporting Multi-gene Cardiac Xenografts From Swine Demonstrate Survival >8 Months and Preclinical Efficacy for Human Clinical Trials

C. Goerlich¹, B. Griffith¹, A. Singh¹, T. Zhang¹, I. Tatarov¹, B. Lewis¹, F. Sentz¹, A. Hershfeld¹, P. Odonkor¹, B. Williams¹, E. Strauss¹, A. Tabatabai², A. Bhutta³, D. Ayares⁴, D. Kaczorowski¹, M. Mohiuddin¹
Limited Immunogenicity of a Single Dose of Sars-cov-2 Mrna Vaccine in Solid Organ Transplant Recipients

B. Boyarsky, M. Ou, R. Greenberg, A. Teles, W. Werbel, R. Avery, A. Tobian, A. Massie, D. Segev, J. Garonzik Wang
Liver and Kidney Transplantation During the Covid-19 Pandemic Period: A Single Center Experience

M. Haberal¹, E. Karakaya¹, A. Akdur¹, E. Ayvazoglu Soy¹, F. Ozcay², E. Baskin³, S. Boyacioglu⁴, A. Torgay⁵, S. Yildirim¹, G. Moray¹, F. Yarbug Karakayali¹
Liver Biopsy as a Predictor in Risk Stratification for Heart Transplant Candidates

S. Tolia¹, T. Al Saadi¹, N. Narang², A. Joshi², C. Sciamanna², S. Pauwaa², G. Macaluso², M. Dia², A. Tatooles³, P. Pappas³, W. Cotts², A. Andrade²
Liver Dysfunction Following Lung Transplantation

E. J. Hyzny¹, E. G. Chan¹, J. P. Ryan¹, T. Harano¹, M. R. Morrell², P. G. Sanchez¹
Liver Kinase B1 Knockdown Induces Platelet-Derived Growth Factor Receptor B Expression in Human Airway Epithelial Cells: A Potential Mechanism for Development of Fibrosis Leading to Chronic Lung Allograft Dysfunction

M. Rahman, J. Lee, R. Ravichandran, T. Fleming, M. Smith, R. Bremner, T. Mohanakumar
Liver Live Donor Champion: Advocacy Training to Facilitate Identification of Living Liver Donors

L. R. Herbst, Y. Yu, A. Love, K. Lee, A. Wells, K. Mohr, A. Massie, A. Gurakar, B. King, D. L. Segev, A. M. Cameron, J. Garonzik Wang
Liver Simulated Allocation Model (LSAM) of a Height-Based Policy Change to Improve Sex Disparity in Liver Transplantation (LT)

S. Bernards¹, E. Lee¹, N. Leung², H. Zhao², M. Akan³, M. Sarkar¹, S. Tayur³, N. Mehta¹
Liver Simulated Allocation Model Does Not Accurately Predict Organ Offer Decisions in Pediatric Liver Transplant Candidates

N. L. Wood¹, D. B. Mogul², E. K. Hsu³, E. R. Perito⁴, G. V. Mazariegos⁵, D. Vanderwerken¹, D. L. Segev², S. Gentry¹
Liver Transplant in Adult Recipients Using Pediatric Deceased Donor Liver Grafts

P. Vargas¹, C. Argo², H. Zachary², M. Stotts², N. Intagliata², P. Northup², S. Pelletier¹, J. Oberholzer¹, N. Goldaracena¹
Liver Transplant Justified at Any Meld Score?

H. Oden-Brunson, E. Godfrey, H. Flores, A. Rana
Liver Transplant Outcomes Using Nationally Allocated Grafts

S. Ohara¹, B. Lizaola-Mayo², P. Morgan², D. Das³, J. Wagler⁴, K. S. Reddy², B. Aqel², A. Moss², C. Jadlowiec²
Liver Transplantation Following Checkpoint Inhibitor Therapy – Timing is Everything

G. T. Schnickel¹, J. Parekh¹, Y. Kono², J. Berumen¹, V. Ajmeera², K. Mekeel¹
Liver Transplantation for COVID-19-associated Cholangiopathy

J. Blondeel¹, P. Meersseman², N. Gilbo¹, I. Jochmans¹, M. Sainz-Barriga¹, J. Pirenne¹, D. Monbaliu¹
Liver Transplantation for Unresectable Colorectal Cancer Liver Metastases: A Multicenter Experience

L. I. Ruffolo¹, K. Sasaki², K. Tomiyama¹, A. Nair¹, M. Orloff¹, B. Al-Judaibi³, M. Levstik³, M. Laryea³, K. Dokus¹, J. Errigo¹, A. Moro², C. Quintini², K. Hashimoto², M. Fujiki², K. Menon², C. Kwon², T. Diago Uso², R. Hernandez-Alejandro¹, F. Aucejo²
Liver Transplantation in Septuagenarians

L. Egbert¹, D. Das¹, S. Ohara², J. Wagler³, G. Mahdi⁴, B. Aqel⁵, A. Moss⁵, K. S. Reddy⁵, C. Jadlowiec⁵
Liver Transplantation with Super Obese Donors (BMI≥50) Grafts: An Acceptable Pathway to Expand the Donor Pool. Analysis of the OPTN/UNOS Liver Transplant Registry

P. Vargas¹, C. Argo², H. Zachary², M. Stotts², N. Intagliata², P. Northup², J. Oberholzer¹, S. Pelletier¹, N. Goldaracena¹
Living Donor Kidney Transplantation Racial Disparities Persist Independent of Social Vulnerability

A. C. Killian¹, M. C. McLeod¹, B. Shelton¹, R. D. Reed¹, P. MacLennan¹, H. Qu¹, B. J. Orandi¹, V. Kumar¹, D. Sawinski², R. M. Cannon¹, D. J. Anderson¹, M. J. Hanaway¹, J. E. Locke¹
Living Donor Liver Transplant for Unresectable Colorectal Metastasis: A Case Series

B. Emmanuel, H. Al-Harakeh, A. Humar, C. Hughes, A. Tevar, M. Molinari, A. Ganoza
Living Donor Total Robotic Renal Transplantation: Early Single Center Experience

M. E. Tobon Lascano, S. Koganti, M. E. Akoad, M. Anastopoulos, C. J. Simon, B. A. Bouthot, E. D. Walshe, Y. L. Cheah
Living Donor versus Deceased Donor Pediatric Liver Transplantation: A Systematic Review and Meta-Analysis of Outcomes

A. Barbetta¹, C. Butler², S. Barhouma², R. Hogen¹, B. Roque¹, H. Schillperoort³, G. Meeberg⁴, J. Shapiro⁵, Y. Kwon¹, R. Kohli⁶, J. Emamaullee¹
Living Organ Donor Perspectives on Covid-19 Vaccines

M. N. Harhay¹, A. Klassen², H. Zaidi¹, M. Mittelman³, R. Bertha³, R. Mannon⁴, K. Lentine⁵
Loneliness in Adults Awaiting Liver Transplantation at 7 U.S. Transplant Centers During the Covid-19 Pandemic

K. Berry¹, D. Kent¹, S. Seetharaman¹, R. Wong¹, Y. Mohamad¹, F. Yao¹, M. Duarte², B. Boyarsky³, R. Rahimi⁴, A. Duarte-Rojo⁵, M. Kappus⁶, M. Volk⁷, D. Ladner⁸, D. Segev³, M. McAdams-DeMarco³, E. Verna⁹, D. Ganger⁸, J. C. Lai¹
Long Term Outcomes of Kidney Donors with Fibromuscular Dysplasia

H. N. Adrogue¹, A. Evans¹, S. A. Hebert¹, H. E. Adrogue¹, D. T. Nguyen², D. Murad¹, E. A. Graviss²
Long Term Outcomes of Kidney Transplantation from Deceased Donors with Terminal Acute Kidney Injury

J. Rogers¹, R. Stratta², A. Farney², G. Orlando², C. Jay², A. Reeves-Daniel³, A. Mena-Gutierrez³, N. Sakhovskaya³, K. Gurung², B. Sharda², J. Rogers²
Long Term Safety and Efficacy of Tocilizumab (anti-il6r, Tcz) Therapy in the Treatment of Refractory Chronic Antibody Mediated Rejection (cabmr) in 25 Pediatric Renal Transplant Recipients

M. Pearl¹, P. Weng¹, A. Dokras², H. Pizzo³, J. Garrison³, C. Butler¹, J. Q. Zhang¹, K. Lim³, E. Reed¹, I. Kim³, M. Haas³, X. Zhang³, R. Ettenger¹, S. Jordan³, D. Puliyanda³
Long Term Survival After Liver Transplantation for Advanced, Unresectable Intrahepatic Cholangiocarcinoma

R. R. McMillan¹, S. Kodali¹, M. Javle², A. Saharia¹, C. M. Mobley¹, M. J. Hobeika¹, A. Shetty¹, D. W. Victor¹, R. McFadden¹, M. Abdelrahim¹, K. Heyne¹, A. O. Gaber¹, R. M. Ghobrial¹
Long-Term Follow-Up of a Phase 2 Clinical Trial to Induce Tolerance in Living Donor Renal Transplant Recipients

J. Leventhal¹, J. Galvin², J. Mathew¹, L. Gallon¹, D. Belshe¹, M. Gibson¹, K. Ravindra³, M. Horwitz³, S. Ildstad⁴
Long-Term Outcomes in Older Kidney Transplant Recipients from Older Donors

E. Cuadrado-Payán, E. Montagud-Marrahi, J. Casals-Urquiza, J. del Risco-Zevallos, D. Cucchiari, P. Ventura-Aguiar, I. Revuelta, G. Piñeiro, N. Esforzado, F. Cofan, J. Ugalde, J. Campistol, F. Oppenheimer, J. Torregrosa, F. Diekmann
Long-term Outcomes of Donation After Cardiac Death and Living Donor Liver Transplant for Primary Sclerosing Cholangitis: An Analysis of UNOS Registry from 2002-2020

T. Kitajima, S. Nagai, T. Ivanics, T. Shamaa, K. Collins, M. Rizzari, A. Yoshida, M. Abouljoud, D. Moonka
Long-term Outcomes of Early Steroid Withdrawal (SW) After Kidney Transplant

D. Vock¹, A. Matas²
Long-Term Renal Outcomes in Lung Transplant Recipients- A Single-Center Five-Year Experience

M. Doraiswamy, E. Obole, P. Singh, T. Pesavento
Longitudinal Antibody Response and Viral Loads in Covid-infected Organ Transplant Recipients

T. M. Marinelli, V. H. Ferreira, M. Ierullo, V. Kulasingham, B. Majchrzak-Kita, C. Rotstein, S. Husain, S. Hosseini, A. Humar, D. Kumar
Longitudinal Quality of Life Assessment in Liver Transplant – Feasibility Study and Early Results

O. M. Siddiqui, P. Polineni, A. J. Thuluvath, C. Loftus
Longitudinal Studies of Blood Anellovirus DNA Prior to Acute Rejection or Major Infection Events in Pediatric Kidney Transplant Recipients (PKTx)

R. Dandamudi, H. Gu, C. Goss, H. Gula, K. Wylie, V. Dharnidharka
Longitudinal Studies of Blood Donor-derived Cell Free DNA (dd-cfDNA) Show Predictable Rise at Time of BK Viremia or Viruria in Pediatric Kidney Transplant Recipients (PKTx)

R. Dandamudi¹, H. Gu¹, C. Goss¹, S. Federman², R. Woodward², S. Dholakia², L. Walther¹, V. Dharnidharka¹
Longitudinal Surveillance, Relative Change Value (RCV) Improve Diagnostic Test Accuracy (DTA) of Donor-Derived Cell Free DNA (dd-cfDNA)

S. Anand, F. Lopez-Verdugo, J. Sanchez-Garcia, L. Dong, M. Fife, J. Krong, D. Morris, T. Srinivas
Longitudinal Variance of Donor Derived Cell Free DNA (dd-cf DNA) in Stable Kidney Transplant (Tx) Patients are Influenced by Donor/Recipient Variables

S. Anand, F. Lopez-Verdugo, J. Sanchez-Garcia, L. Dong, M. Fife, J. Krong, D. Morris, T. Srinivas
Low Immunogenic Donors Improve Kidney Transplant Survival in Sensitized Recipients

D. Bekbolsynov¹, R. Green², B. Mierzejewska¹, M. Rees¹, S. Stepkowski¹
Low Immunogenic Donors Improved Survival of Kidney Transplants in African American Recipients

D. Bekbolsynov¹, R. Green², B. Mierzejewska¹, O. Ekwenna¹, M. Rees¹, S. Stepkowski¹
Low Socio-economic Status is Associated with Lower Kidney Graft Survival and Increased Risk of Graft Failure Due to Acute Rejection

W. Xie¹, G. Vrakas¹, S. H. Gray¹, A. Haririan², J. R. Scalea¹, J. S. Bromberg¹, D. G. Maluf¹, R. P. Meier¹
LTβR Engagement Regulates Treg Migration, Stability and Suppressor Function

V. Saxena¹, W. Piao¹, L. Li¹, Y. Xiong¹, M. W. Shirkey¹, J. Iyyathurai¹, R. Lakhan¹, R. Abdi², J. Bromberg¹
Lung Transplant Outcomes Based on Immunosuppressive Regimen at Discharge: Data from the US Scientific Registry of Transplant Recipients (SRTR)

W. Fitzsimmons¹, J. Erdman², J. Wolfram³, D. Nimke², R. Croy², X. Wang², T. Weaver⁴, D. Schladt⁴
Lung Transplant Recipients Developing Early DSAs are Characterized by a Shift Towards Memory B Cells Directly After Transplantation

S. Christoph¹, A. Hitz¹, R. Bellmàs Sanz¹, J. Kühne¹, B. Wiegmann², F. Ius², J. Salman², E. Chichelnitskiy¹, T. Siemeni², W. Sommer³, A. Haverich², G. Warnecke³, C. Falk¹
Lung Transplant Recipients with Severe Acute Respiratory Syndrome-Coronavirus 2 Infection and Asymptomatic Carriers Waiting for Lung Transplantation Induce Circulating Exosomes with Severe Acute Respiratory Syndrome-Coronavirus 2 Spike Protein S2

S. Bansal, S. Tokman, T. Fleming, M. Smith, R. Bremner, T. Mohanakumar
Lung Transplantation After Ex-Vivo Lung Perfusion versus Static Cold Storage: A Single Institution Cost Analysis

S. E. Halpern¹, S. J. Kesseli², S. Au¹, M. K. Krischak¹, D. G. Olaso¹, H. Smith³, G. Tipton², I. Jamieson³, J. C. Haney², J. A. Klapper², M. G. Hartwig²
Lymphotoxin Beta Receptor Regulates Treg Migration and Suppression by Modulating Draining Lymphatic Structure

V. Saxena¹, W. Piao¹, L. Li¹, M. W. Shirkey¹, J. Iyyathurai¹, R. Lakhan¹, R. Abdi², J. Bromberg¹